Moderna Cash from Investing (Quarterly) Analysis

Moderna Inc (MRNA)

41.11 +2.86 (+7.48%) USD | NASDAQ | Nov 22, 16:00

41.35 +0.24 (+0.58%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	721.00M
June 30, 2024	1.649B
March 31, 2024	118.00M
December 31, 2023	-538.00M
September 30, 2023	789.00M
June 30, 2023	1.944B
March 31, 2023	2.011B
December 31, 2022	-1.048B
September 30, 2022	945.00M
June 30, 2022	-1.152B
March 31, 2022	-3.921B
December 31, 2021	-1.138B
September 30, 2021	-3.327B
June 30, 2021	-3.878B

Date	Value
March 31, 2021	-180.00M
December 31, 2020	-190.00M
September 30, 2020	-1.179B
June 30, 2020	13.00M
March 31, 2020	-316.00M
December 31, 2019	130.29M
September 30, 2019	113.37M
June 30, 2019	-246.90M
March 31, 2019	-11.76M
December 31, 2018	6.173M
September 30, 2018	116.08M
June 30, 2018	-11.64M
March 31, 2018	-483.70M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-3.921B

Minimum

Mar 2022

2.011B

Maximum

Mar 2023

-427.34M

Average

-185.00M

Median

Cash from Investing (Quarterly) Benchmarks

Eli Lilly and Co	-4.005B
Merck & Co Inc	-3.845B
Pfizer Inc	-2.057B
Novavax Inc	31.91M
Biogen Inc	-1.181B

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-1.566B
Cash from Financing (Quarterly)	11.00M
Free Cash Flow	-3.956B
Free Cash Flow Per Share (Quarterly)	-4.303
Free Cash Flow to Equity (Quarterly)	-1.717B
Free Cash Flow to Firm (Quarterly)	-1.717B
Free Cash Flow Yield	-24.88%